2003
Cardiac Resynchronization Therapy-Defibrillator Represents the World''s Most Advanced System Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Corporate Integrity Agreement Strengthens Guidant''s Commitment to Compliance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has entered into a corporate integrity...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2003 earnings conference...
European Approval Received; New Technology''s Clinical Trial Demonstrated Excellent Results Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Financial Guidance Updated Based on Strong Sales Companywide; Quarterly Dividend to be Paid June 30 INDIANAPOLIS - Guidant Corporation (NYSE: GDT) today announced that the company has made a $10...
No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced plans to...
X Technologies Receives FX miniRAIL U.S. Food and Drug Administration Approval; Conditions of X Technologies Acquisition Fulfilled; Agreement Expected to Close This Quarter Indianapolis, Ind. -...
Company''s Management to Provide Update on Recent Developments Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - EndoVascular Technologies, Inc. (EVT), a subsidiary of Guidant Corporation, today announced that it has entered into a...
Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world...